Neurovascular and Immune Mechanisms in AD Pathogenesis

About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
July 01, 2021 - June 30, 2023
Grant ID
A2021019F
Mentor(s)
Katerina Akassoglou, PhD, Gladstone Institutes
Goals
By elucidating the mechanisms of blood clotting factors in immune activation and memory loss, our study will provide the basis for novel strategies for therapeutic intervention in AD.
Summary
This proposal will use a multi-pronged experimental design to examine the cerebrovascular mechanisms regulating neuronal dysfunction in AD. We will use state-of-the-art imaging to study neurons in living mice and with subcellular resolution. We will determine the transcriptional machinery of neurotoxic brain immune cells in the brain of AD mice at the single-cell level.
Unique and Innovative
This project will fill a major knowledge gap, namely the mechanisms that link cerebrovascular damage with pathogenic immune activation and neuronal dysfunction in AD. Emerging evidence shows that cerebrovascular pathology, BBB disruption, and fibrinogen deposition in AD brains is not merely a consequence of disease but plays a causal role in inflammation, oxidative stress and neurodegeneration. This proposal will discover novel neurotoxic mechanisms and therapeutic targets for AD at the neurovascular interface.
Foreseeable Benefits
This proposal will revolutionize our understanding of the cellular and molecular triggers of neurodegeneration in AD. By elucidating the molecular mechanism of blood clotting factors in brain immune activation and memory loss, our study will provide the basis for novel strategies for therapeutic intervention to protect from cerebrovascular dysfunction in AD.
Grants
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Dong Kyu Kim, PhD
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Dong Kyu Kim, PhD
Alzheimer's Disease Research
Cancer-Like Metabolic Changes in Alzheimer's Disease Neurons
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Jerome Mertens, PhD
Cancer-Like Metabolic Changes in Alzheimer's Disease Neurons
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Jerome Mertens, PhD